research_logo
home publications nav_funding nav_opport links
 

Publications

2014
1.      Liu Y, Lu X, Xiang FL, Poelmann RE, Gittenberger-de Groot AC, Robbins J, Feng Q. Nitric oxide synthase-3 deficiency results in hypoplastic coronary arteries and postnatal myocardial infarction. Eur Heart J. 2014;35:920-31.
2.     Moazzen H, Lu X, Ma NL, Velenosi TJ, Urquhart BL, Wisse LJ, Groot AC, Feng Q. N-Acetylcysteine prevents congenital heart defects induced by pregestational diabetes. Cardiovasc Diabetol. 2014;13:46. This is a 'Highly Accessed' article.
3.     Arnold P, Lu X, Amirahmadi F, Brandl K, Arnold JMO, Feng Q. Recombinant human annexin A5 inhibits pro-inflammatory response and improves cardiac function and survival in mice with endotoxemia. Critical Care Med. 2014;42:e32-41.
2013
1.     Mitchell AJ, Sabondjian E, Balckwood KJ, Sykes J, Deans L, Feng Q, Stodilka RZ, Prato F, Wisenberg G. Comparison of the myocardial clearance of endothelial progenitor cells injected early vs. late into reperfused or sustained occlusion myocardial infarction. Intl J Cardiovasc Imaging. 2013; 29:497-504.
2.     Xiang FL, Lu X, Liu Y, Feng Q. Cardiomyocyte-specific overexpression of human stem cell factor protects against myocardial ischemia and reperfusion injury. Intl J Cardiol. 2013;168: 3486-94.
3.     Liu Y, Lu X, Xiang FL, Lu M, Feng Q. Nitric oxide synthase-3 promotes embryonic development of atrioventricular valves. PLoS ONE. 2013;8:e77611.
2012
1.     Hu H, Xenocostas A, Chin-Yee N, Lu X, Chin-Yee I, Feng Q. Transfusion of fresh but not stored blood reduces infarct size and improves cardiac function following acute myocardial infarction in anemic rats. Critical Care Med. 2012; 40:740-746.
2.     Yan Q, Feng Q, Beier F. Reduced chondrocyte proliferation, earlier cell cycle exit and increased apoptosis in neuronal nitric oxide synthase-deficient mice. Osteoarthritis Cartilage. 2012;20:144-151.
3.     Zhang T, Lu X, Arnold P, Liu Y, Baliga R, Huang H, Bauer JA, Liu YS, Feng Q. Mkp-1 inhibits myocardial tumor necrosis factor-alpha expression and improves cardiac function during endotoxemia. Cardiovasc Res. 2012;93:471-479.
4.     Zhang T, Lu X, Li J, Chidiac P, Sims SM, Feng Q. Inhibition of Na/K-ATPase promotes myocardial tumor necrosis factor-alpha protein expression and cardiac dysfunction via calcium/mTOR signaling in endotoxemia. Basic Res Cardiol 2012;107(2):254.
5.     Detombe SA, Xiang FL, Dunmore-Buyze J, White JA, Feng Q, Drangova M. Rapid micro-computed tomography suggests cardiac enlargement occurs during conductance catheter measurements in mice. J Appl Physiol. 2012; 113:142-148.
6.     Liu Y, Feng Q. NOing the heart: Role of nitric oxide synthase-3 in heart development (Review). Differentiation 2012; 84:54-61.
7.     Chin-Yee I, Xenocostas A, Feng Q. Current randomized clinical trials of red cell storage duration and patient outcomes (Response to the Editor). Critical Care Med. 2012; 40:2927-2928.
2011
1.     Turner J, Xiang FL, Feng Q, Wagner GF. The renal stanniocalcin-1 gene is differentially regulated by hypertonicity and hypovolemia in the rat. Mol Cell Endocrinol. 2011; 331:150-157.
2.     Zhang T, Lu X, Beier F, Feng Q. Rac1 activation induces tumor necrosis factor-alpha expression and cardiac dysfunction in endotoxemia. J Cell Mol Med. 2011;15:1109-1121.
3.     Hammoud L, Lu X, Lei M, Feng Q. Deficiency in TIMP-3 Increases cardiac rupture and mortality post-myocardial infarction via EGFR signalling: Beneficial effects of cetuximab. Basic Res Cardiol. 2011; 106:459-471.
4.     Wu Y, Lu X, Xiang FL, Lui EMK, Feng Q. North American ginseng protects the heart from ischemia and reperfusion injury via upregulation of endothelial nitric oxide synthase. Pharmacol Res. 2011; 64:195-202.
5.     Wang G, Yan Q, Woods A, Aubrey LA, Feng Q, Beier F. iNOS/nitric oxide signaling mediates the mitogenic activity of Rac1 during endochondral bone growth. J Cell Sci 2011; 124:3405-3413.
6.     Nong Z, O'Neil C, Lei M, Gros R, Watson A, Li S, Frontini MJ, Feng Q, Pickering JG. Type I collagen cleavage is essential for effective fibrotic repair following myocardial infarction. Am J Pathol. 2011; 179:2189-2198.
7.     Feng Q, Scott J. Nitric Oxide, from its chemistry to biology and disease (Editorial). Open Nitric Oxide J. 2011; 3(Suppl 1-M1): 6-7.
8.     Burger DE, Feng Q. Protective role of nitric oxide against cardiac arrhythmia - An update (Review). Open Nitric Oxide J. 2011; 3 (Suppl 1-M6):38-47.
2010
1.     Feng B, Chen S, George B, Feng Q, Chakrabarti S. miR133a regulates cardiomyocyte hypertrophy in diabetes. Diabetes Metab Res Rev. 2010;26:40-49.
2.     Hu H, Xenocostas A, Chin-Yee I, Lu X, Feng Q. Effects of anemia and blood transfusion in acute myocardial infarction in rats. Transfusion. 2010; 50:243-251.
3.     Mitchell AJ, Sabondjian E, Sykes J, Deans L, Zhu W, Lu X, Feng Q, Prato FS, Wisenberg G. Comparison of initial cell retention and clearance kinetics following subendocardial or subepicardial injections of endothelial progenitor cells in a canine myocardial infarction model. J Nuclear Med. 2010;51:413-417.
4.     Yan Q, Feng Q, Beier F. Endothelial nitric oxide synthase deficiency results in reduced chondrocyte proliferation and endochondral bone growth. Arthritis & Rheumatism. 2010; 62:2013-2022.
5.     Kennedy KAM, Ostrakhovitch EA, Sandiford SDE, Dayarathna T, Xie X, Waese EYL, Chang WY, Feng Q, Skerjanc IS, Stanford WL, Li SSC. Mammalian numb interacting protein1/dual oxidase maturation factor1 directs neuronal fate in stem cells. J Biol Chem 2010;285:17974-17985.
6.     Xiang FL, Lu X, Strutt B, Hill DJ, Feng Q. NOX2 deficiency protects against streptozotocin-induced ? cell destruction and development of diabetes in mice. Diabetes, 2010; 59:2603-2611.
7.     Xenocostas A, Hu H, Chin-Yee N, Lu X, Chin-Yee I, Feng Q. Erythropoietin is equally effective as fresh blood transfusion at reducing infarct size in anemic rats. Critical Care Med. 2010; 38:2215-2221.
8.     Zhang T, Feng Q. Nitric oxide and calcium signaling on myocardial tumor necrosis factor-alpha expression and cardiac dysfunction in sepsis (review). Can J Physiol Pharmacol. 2010; 88:92-104.
2009
1.     Burger DE, Xiang F, Hammoud L, Lu X, Feng Q. Role of heme oxygenase-1 in the cardioprotective effects of erythropoietin during myocardial ischemia and reperfusion. Am J Physiology: Heart and Circ Physiol. 2009; 296:H84-H93.
2.     Peng T, Zhang T, Lu X, Feng Q. JNK1/c-fos inhibits cardiomyocyte TNF-alpha expression via a negative crosstalk with ERK and p38 MAPK in endotoxemia. Cardiovasc Res. 2009; 81:733-741.
3.     Li N, Lu X, Zhao X, Xiang FL, Xenocostas A, Karmazyn M, Feng Q. Endothelial nitric oxide synthase promotes mesenchymal stromal cell migration towards the ischemic myocardium through upregulation of SDF-1alpha. Stem Cells. 2009; 27:961-970. IF: 7.7
4.     Hammoud L, Burger DE, Lu X, Feng Q. Tissue inhibitor of metalloproteinase-3 inhibits neonatal mouse cardiomyocyte proliferation via EGFR/JNK/SP-1 signaling. Am J Physiology: Cell Physiol. 2009; 296:C735-C745.
5.     Burger DE, Xiang FL, Hammoud L, Jones DL, Feng Q. Erythropoietin protects the heart from ventricular arrhythmia during ischemia and reperfusion via neuronal nitric oxide synthase. J Pharmacol Exp Ther. 2009; 329:900-907.
6.     Pocrnich C, Liu H, Feng M, Peng T, Feng Q, Hutnik C. p38 mitogen-activated protein kinase protects human retinal pigment epithelial cells exposed to oxidative stress. Can J Ophthalmol. 2009; 44:431-436.
7.     Hu H, Li X, Li Y, Wang L, Mehta S, Feng Q, Chen R, Peng T. Calpain-1 induces apoptosis in pulmonary microvascular endothelial cells under septic conditions. Microvasc Res. 2009; 78:33-39.
8.     Li Y, Li Y, Feng Q, Arnold JMO, Peng T. Calpain activation contributes to hyperglycemia-induced apoptosis in cardiomyocytes. Cardiovasc Res. 2009; 84:100-110.
9.     Shen E, Li Y, Li Y, Tang CM, Feng Q, Arnold JMO, Peng T. Rac1 is required for cardiomyocyte apoptosis during hyperglycemia. Diabetes. 2009; 58:2386-2395.
10.     Burger DE, Lu X, Lei M, Xiang F, Hammoud L, Jiang M, Wang H, Jones DL, Sims SM, Feng Q. Neuronal nitric oxide synthase protects against myocardial infarction-induced ventricular arrhythmia and mortality in mice. Circulation. 2009; 120:1345-1354.
- Circulation Editors' Picks: Most read articles in arrhythmia and electrophysiology. Circulation 2011;124:e261-e275.
11.     Xiang FL, Lu X, Hammoud L, Zhu P, Robbins J, Feng Q. Cardiomyocyte specific overexpression of human stem cell factor improves cardiac function and survival post myocardial infarction in mice. Circulation. 2009; 120:1065-1074.
- Circulation Editors' Picks: Most read articles in heart failure. Circulation 2011; 124:e469-e482.
12.     Burger D, Xenocostas A, Feng Q. Molecular basis of cardioprotection by erythropoietin (Review). Current Mol Pharmacol 2009; 2:56-69.
2008
1.     Peng T, Shen E, Fan J, Zhang Y, Arnold JM, Feng Q. Disruption of phospholipase Cgamma1 signalling attenuates cardiac tumor necrosis factor-alpha expression and improves myocardial function during endotoxemia. Cardiovasc Res. 2008;78:90-97. IF: 5.9
2.     Detombe SA, Ford NL, Xiang F, Lu X, Feng Q, Drangova M. Longitudinal follow-up of cardiac structure and functional changes in an infarct mouse model using retrospectively gated micro-computed tomography. Investigative Radiology. 2008; 43:520-529.
3.     Jackson PEM, Feng Q, Jones DL. Nitric oxide depresses connexin 43 after myocardial infarction in mice. Acta Physiol. 2008; 194:23-33.
2007
1.     Yu G, Peng T, Feng Q, Tyml K. Abrupt reoxygenation of microvascular endothelial cells after hypoxia activates ERK1/2 and JNK1, leading to NADPH oxidase-dependent oxidant production. Microcirculation. 2007; 14:1-12.
2.     Geoghegan-Morphet N, Burger D, Lu X, Sathish V, Peng T, Sims SM, Feng Q. Role of neuronal nitric oxide synthase in lipopolysaccharide-induced tumor necrosis factor-alpha expression in neonatal mouse cardiomyocytes. Cardiovasc Res. 2007; 75:408-416. Corrigendum published in Cardiovasc Res. 2009; 81:814.
3.     Hammoud L, Xiang F, Lu X, Brunner F, Leco K, Feng Q. Endothelial nitric oxide synthase promotes neonatal cardiomyocyte proliferation by inhibiting tissue inhibitor of metalloproteinase-3 expression. Cardiovasc Res. 2007; 75:359-68.
2006
1.     Lu X, Hamilton JA, Shen Ji, Jones DL, Potter RF, Arnold JMO, Feng Q. Role of tumor necrosis factor-alpha in myocardial dysfunction and apoptosis during hindlimb ischemia and reperfusion. Critical Care Medicine. 2006; 34:484-491.
2.     Burger DE, Lei M, Geoghegan-Morphet N, Lu X, Xenocostas A, Feng Q. Erythropoietin protects cardiomyocytes from apoptosis via up-regulation of endothelial nitric oxide synthase. Cardiovascular Res. 2006; 72:51-59. This paper was one of most downloaded papers in this journal in 2006 (see Cardiovasc Res. 73:619-622, 2007).
3.     Lepic E, Burger DE, Lu X, Song W, Feng Q. Lack of endothelial nitric oxide synthase decreases cardiomyocyte proliferation and delays cardiac maturation. Am J Physiol: Cell Physiol. 2006; 291:C1240-C1246.
4.     Feng Q. Beyond erythropoiesis, the anti-inflammatory effects of erythropoietin (Editorial). Cardiovasc Res. 2006; 71:615-617.
2005
1.     Peng T, Lu X, Feng Q. NADH oxidase signalling induces cyclooxygenase-2 expression during lipopolysaccharide stimulation in cardiomyocytes. FASEB J. 2005;19:293-295.
2.     Rui T, Feng Q, Lei M, Peng T, Zhang J, Xu M, Abel ED, Xenocostas A, Kvietys PR. Erythropoietin prevents the acute myocardial inflammatory response induced by ischemia/reperfusion in vitro and in vivo: role of AP-1. Cardiovasc Res. 2005; 65:719-727.
3.     Peng T, Lu X, Feng Q. Pivotal role of gp91phox-containing NADH oxidase in lipopolysaccharide-induced tumor necrosis factor-alpha expression and myocardial depression. Circulation. 2005;111:1637-1644.
4.     Wang YX, Martin-McNulty B, da Cunha V, Vincelette J, Lu X, Feng Q, Halks-Miller M, Mahmoudi M, Schroeder M, Subramanyam B, Tseng JL, Deng GD, Schirm S, Johns A, Kauser K, Dole WP, Light DR. Inhibition of Rho-kinase by fasudil attenuated angiotensin II-induced abdominal aortic aneurysm in apolipoprotein E deficient mice: Role of apoptosis. Circulation. 2005;111:2219-2226.
5.     Razavi HM, Hamilton JA, Feng Q. Modulation of apoptosis by nitric oxide: Implications in myocardial ischemia and heart failure (Review). Pharmacology & Therapeutics 2005; 106:147-162.
6.     Feng Q. Postnatal consequences of prenatal cocaine exposure and myocardial apoptosis: Does cocaine in utero imperil the adult heart (Commentary)? Br J Pharmacol 2005; 144:887-888.
7.     Xiang F, Feng Q. Regulation of cardiovascular function by nitric oxide (Expert short review). Chinese J Hypertension 2005; 13:673-675.
2004
1.     McCarter SD, Akyea T, Lu X, Bihari A, Scott JR, Badhwar A, Dungey AA, Harris KA, Feng Q, Potter RF. Heme oxygenase induction is a critical mechanism preventing progressive liver injury during the systemic inflammatory response syndrome. Surgery. 2004;136:67-75.
2.     Tran KL, Lu X, Lei M, Feng Q, Wu Q. Up-regulation of corin gene expression in hypertrophic cardiomyocytes and failing myocardium. Am J Physiol: Heart Circ Physiol. 2004;287:H1625-H1631.
3.     Moe G, Marin-Garcia J, Konig A, Lu X, Feng Q. In vivo TNF-alpha inhibition ameliorates cardiac mitochondrial dysfunction, oxidative stress, and apoptosis in experimental heart failure. Am J Physiol: Heart Circ Physiol. 2004;287:H1813-1820.
2003
1.     Peng T, Lu X, Lei M, Feng Q. Endothelial nitric oxide synthase enhances lipopolysaccharide-stimulated TNF-alpha expression via cAMP-mediated p38 MAPK pathway in cardiomyocytes. J Biol Chem. 2003;278:8099-8105.
2.     Peng T, Lu X, Lei M, Moe GW, Feng Q. Inhibition of p38 MAPK decreases myocardial TNF-alpha expression and improves myocardial function and survival during acute endotoxemia in mice. Cardiovasc Res. 2003;59:893-900.
3.     Rui T, Cepinskas G, Feng Q, Kvietys PR. Delayed preconditioning in cardiac myocytes with respect to neutrophil transendothelial migration: role of SOD and NOS. Cardiovasc Res. 2003;59:901-911.
2002
1.     Moe GW, Naik G, Kornig A, Lu X, Feng Q. Early and persistent activation of myocardial apoptosis, bax and caspase-3: insights into mechanisms of progression of heart failure. Pathophysiology. 2002;8:183-192.
2.     Feng Q, Song W, Lu X, Hamilton J, Lei M, Peng T, Yee SP. Development of heart failure and congenital septal defects in mice lacking endothelial nitric oxide synthase. Circulation. 2002;106:873-879. This paper was featured on the cover of Circulation on Aug. 13, 2002.
3.     Zhao X, Lu X, Feng Q. Deficiency in endothelial nitric oxide synthase impairs myocardial angiogenesis in mice. Am J Physiology: Heart Circ Physiol 2002; 283:H2371-H2378.
2001
1.     Stathopulos PB, Lu X, Shen J, Scott JA, Hammond JR, McCormack DG, Arnold JMO, Feng Q. Increased L-arginine uptake and inducible nitric oxide activity in aortas of rats with heart failure. Am J Physiol, Heart Circ Physiol. 2001; 280:H859-H867.
2.     Rui T, Cepinskas G, Feng Q, Ho YS, Kvietys PR. Cardiac myocytes exposed to anoxia/reoxygenation promote neutrophil transendothelial migration. Am J Physiol, Heart Circ Physiol. 2001; 281:H440-H447.
3.     Feng Q, Lu X, Jones DL, Shen J, Arnold JMO. Increased inducible nitric oxide synthase expression contributes to myocardial dysfunction and higher mortality post myocardial infarction in mice. Circulation. 2001;104:700-704.
4.     Chen L, Gan XT, Haist JV, Feng Q, Lu X, Chakrabarti S, Karmazyn M. Attenuation of compensatory right ventricular hypertrophy and heart failure following monocrotaline
2000
1.     Feng Q, Callow ID, Lambert ML, Arnold JMO. Venous neuropeptide Y receptor responsiveness in patients with chronic heart failure. Clin Pharmacol Ther. 2000; 67:292-298.
2.     Song W, Lu X, Feng Q. Tumor necrosis factor-alpha induces apoptosis via inducible nitric oxide synthase in neonatal mouse cardiomyocytes. Cardiovasc Res. 2000; 45:595-602.
3.     induced pulmonary vascular injury by Na+-H+ exchange inhibitor cariporide. J Pharmacol Exp Ther. 2001;298:469-476.
1999
1.     Humphreys RA, Chakrabart S, Haist JV, Feng Q, Arnold JMO, Karmazyn M. Dietary NHE-1 inhibitor cariporide reduces acute response to coronary artery occlusion and reperfusion. Am J Physiol. 1999; 276:H749-H757.
2.     Lambert ML, Callow ID, Feng Q, Arnold JMO. The effects of age on human venous responsiveness in neuropeptide Y. Br J Clin Pharmacol. 1999; 47:83-89.
3.     Feng Q, Fortin AJ, Lu XR, Arnold JMO. Effects of L-arginine on endothelial and cardiac function in rats with congestive heart failure. Eur J Pharmacol. 1999; 376:37-44.
4.     Feng Q, Sun XY, Lu XR, Edvinsson L, Hedner T. Decreased responsiveness of vascular postjunctional alpha1-, alpha2-adrenoceptors and neuropeptide Y1 receptors in rats with heart failure. Acta Physiol Scand. 1999; 166:285-291.
1990-1998
1.     Feng Q, Lu XR, Fortin AJ, Pettersson A, Hedner T, Kline RL, Arnold JMO. Elevation of an endogenous inhibitor of nitric oxide synthase in experimental congestive heart failure. Cardiovasc Res. 1998;37:667-675.
2.     Li S, Hwang FL, Feng Q, Liu J, Fan SX, McKenna TM. Overexpression of protein kinase C enhances LPS-induced nitric oxide formation in vascular smooth muscle cells. J Cell Physiol. 1998; 176:402-411.
3.     Callow ID, Campisi P, Lambert ML, Feng Q, Arnold JMO. Enhanced in vivo alpha1- and alpha2-adrenoceptor-mediated venoconstriction with indomethacin in humans. Am J Physiol. 1998; 275:H837-H843.
4.     Feng Q, Bergdahl A, Lu XR, Sun XY, Edvinsson L, Hedner T. Vascular alpha-2 adrenoceptor function is decreased in rats with congestive heart failure. Cardiovasc Res. 1996; 31:577-584.
5.     Feng Q, Sun XY, Hedner T. Cardiovascular responses and interactions by neuropeptide Y in congestive heart failure rat. Blood Pressure. 1996; 5:312-318.
6.     Arnold JMO, Feng Q, Delaney GA, Teasell RW. Increased venous alpha-adrenoceptor responsiveness in quadriplegic patients with autonomic dysreflexia. Clin Autonomic Res. 1995, 5:267-270.
7.     Sun XY, Feng Q, Edvinsson L, Thomas Hedner. Cardiovascular and renal effects of alpha-trinositol in ischemic heart failure rats. Life Sci. 1995; 57:1197-1211.
8.     Bergdahl A, Valemarsson S, Pantev E, Ottoson A, Feng Q, Sun XY, Hedner T, Edvinsson L. Modulation of vascular contractile responses to alpha1 and alpha2 adrenergic and neuropeptide Y1 receptor stimulation in rats with ischaemic heart failure. Acta Physiol Scand. 1995; 154: 429-437.
9.     Feng Q, Carlsson S, Thoren P, Hedner T. Characteristics of renal sympathetic nerve activity in experimental congestive heart failure in the rats. Acta Physiol Scand. 1994; 150:259-266.
10.     Feng Q, Hedner T, Andersson B, Lundberg JM, Waagstein F. Cardiac neuropeptide Y and noradrenaline balance in patients with congestive heart failure. Br Heart J. 1994; 71:261-267.
11.     Fu LX, Sun XY, Feng Q, Liang QM, Hedner T, Hjalmarson A. Down-regulation of endothelin receptors in mesenteric artery in chronic ischemic heart failure in rats. J Cardiovasc Pharmacol. 1993; 22: 177-182.
12.     Sun XY, Hedner T, Feng Q, Edvinsson L. Inhibition of endothelin (ET-1) induced pressor responses by the endothelin (ETA) receptor antagonist FR139317 in the pithed rat. Blood Pressure. 1993; 1: 20-24.
13.     Fu LX, Feng Q, Liang QM, Sun XY, Hedner T, Hjarlmarson A. Hypersensitivity of Gi protein mediated muscarinic receptor adenylyl cyclase in ischaemic heart failure in the rat. Cardiovasc Res. 1993; 27:2065-2070.
14.     Feng Q, Hedner T, Andersson B, Lundberg JM, Waagstein F. Neuropeptide Y is co-released with norepinephrine in patients with congestive heart failure. Chinese J Hyperten. 1993; 1:16-23.
15.     Sun XY, Feng Q, Gong QL, Edvinsson L, Hedner T. Cardiovascular and renal effects of gamma-MSH in spontaneously hypertensive and normotensive Wistar Kyoto rats. Am J Physiol. 1992; 262:R77-R84.
16.     Feng Q, Carlsson S, Thoren P, Hedner T. Effects of clonidine on renal sympathetic nerve activity, natriuresis and diuresis in chronic congestive heart failure rats. J Pharmacol Exp Ther. 1992; 261: 1129-1135.
17.     Feng Q, Carlsson S, Thoren P, Hedner T. Clonidine influences renal sympathetic nerve activity and renal function in experimental heart failure. J Hypertens. 1991; 9:S58-S59.
18.     Sun XY, Feng Q, Edvinsson L, Hedner T. Gamma-melanocyte-stimulating hormone have pressor and natriuretic effects in spontaneously hypertensive and Wistar-Kyoto rats. J Hypertens. 1991; 9:S346-S347.
19.     Feng Q, Hedner T. Endothelium-derived relaxing factor (EDRF) and nitric oxide (NO). I. Physiology, pharmacology and pathophysiological implications. Clin Physiol. 1990; 10:507-426. (Review, 180 refs)
20.     Feng Q, Hedner T. Endothelium-derived relaxing factor (EDRF) and nitric oxide (NO). II. Physiology, pharmacology and pathophysiological implications. Clin Physiol. 1990; 10:503-526. (Review, 174 refs)
21.     Feng Q, Hedner T, Hedner J, Pettersson A. The blunted renal response to atrial natriuretic peptide in congestive heart failure rats is reversed by the alpha2-adrenergic agonist clonidine. J Cardiovasc Pharmacol. 1990; 16:776-782.